FeedChannel feedchannel@feedchannel.online https://www.feedchannel.online en-us Visualplatform http://blogs.law.harvard.edu/tech/rss FeedChannel episodic no https://www.feedchannel.online/files/rv1.7/sitelogo.gif https://www.feedchannel.online http://www.feedchannel.online/antibiotics-probiotics-and <p><b>Speaker: </b>Prof Sam BROWN, Georgia Institute of Technology, USA <br><br>Drug resistance is an important issue. What about evolutionary robustness in relation of treatment efficacy? Focusing on anti-virulence and anti-resistance features become more and more critical for the development of future solutions vs traditional anti-microbial strategies. Conditional strategies need to be developed to efficiently fight antimicrobial resistance.<br><br><br><b>6th international Conference on Poultry Intestinal Health (IHSIG)</b><br></p><p><a href="http://www.feedchannel.online/antibiotics-probiotics-and"><img src="http://www.feedchannel.online/64968570/66498938/1ff0220a91af059f1d1040affc0b87cd/standard/download-4-thumbnail.jpg" width="600" height="338"/></a></p> http://www.feedchannel.online/photo/66498938 Tue, 02 Jul 2019 00:00:00 GMT Antibiotics, probiotics and anti-virulence: balancing efficacy and evolution Speaker: Prof Sam BROWN, Georgia Institute of Technology, USA Drug resistance is an important issue. What about evolutionary robustness in relation of treatment efficacy? Focusing on anti-virulence and anti-resistance features become more and more critical for the development of future solutions vs traditional anti-microbial strategies. Conditional strategies need to be developed to efficiently fight antimicrobial resistance.6th international Conference on Poultry Intestinal Health (IHSIG) Speaker: Prof Sam BROWN, Georgia Institute of Technology, USA Drug resistance is an important issue. What about evolutionary robustness in relation of treatment efficacy? Focusing on anti-virulence and anti-resistance features become more and more... FeedChannel 38:08 <p><b>Speaker: </b>Prof Sam BROWN, Georgia Institute of Technology, USA <br><br>Drug resistance is an important issue. What about evolutionary robustness in relation of treatment efficacy? Focusing on anti-virulence and anti-resistance features become more and more critical for the development of future solutions vs traditional anti-microbial strategies. Conditional strategies need to be developed to efficiently fight antimicrobial resistance.<br><br><br><b>6th international Conference on Poultry Intestinal Health (IHSIG)</b><br></p><p><a href="http://www.feedchannel.online/antibiotics-probiotics-and"><img src="http://www.feedchannel.online/64968570/66498938/1ff0220a91af059f1d1040affc0b87cd/standard/download-4-thumbnail.jpg" width="600" height="338"/></a></p> alternate states antibiotics anti-resistance anti-virulence drugs asymptomatic carriage states chronic infections conditional strategies cooperative virulence cystic fibrosis efficacy evolution-proof gallium IHSIG microbiomes models prediction resistance robustness symptoms synthetic communities transitions treatments